Genoa is excited to support your continuing professional development (CPD) in the behavioral health arena. We are once again partnering with the American Association of Psychiatric Pharmacists (AAPP) to provide you with psychiatric specialty training through select modules from AAPP’s Psychiatric Pharmacotherapy Review Course!
Carolanne Wartman, PharmD, BCPS, BCPP (she/her) Clinical Assistant Professor of Pharmacy Practice The University of Mississippi School of Pharmacy Jackson, MS
Kaitlyn Q. Weslosky, PharmD, BCPP Clinical Pharmacy Provider- Psychiatry Robert J. Dole VA Medical Center Wichita, KS
Dr. Taylor Nichols, PharmD, BCPP, explains how to embrace harm reduction.
Sophie Robert, BPharm, PharmD, BCPP discusses provider concerns and assumptions about patients' use of psychotropics during pregnancy.
Psychiatric pharmacists experience a significant variability in their prescriptive authority. Their demographics reflect changes in residency accreditation and increased numbers of psychiatric residencies within VA facilities. Those with prescriptive authority reported treating psychiatric and medical conditions, creating added value.
Carla Cobb, PharmD, BCPP, FAAPP Psychiatric Pharmacist Capita Consulting Billings, MT
Andrew Williams, PharmD, BCPP, FAAPP Supervising Clinical Pharmacist, Behavioral Health Riverside University Health System Riverside, CA
The application portal is closed.
Substance use disorders (SUD) are a major public health crisis impacting families, communities and society.
Lack of access to care is the root cause for the mental health crisis in the U.S. Demand for mental health services is greater than ever and services are not keeping pace.
What you need to know about quitting vaping.
What you need to know about suicide warnings on medications.
Dr. Sadie Roestenburg, PharmD, BCPS, talks about managing Medication Assisted Treatment (MAT).
The current practice of psychiatric pharmacy is incredibly varied in terms of practice setting, activities performed, and services provided. This paper provides a description of the current clinical landscape of psychiatric pharmacy. This study is notable for being the first comprehensive survey of current psychiatric pharmacy practice in the United States.
According to the literature reviewed, there is evidence to suggest that having a psychiatric pharmacist on the health care team improves patient outcomes across a wide variety of inpatient and outpatient settings from general practice to specialized services.
Last Updated: 2022-02-07
One of AAPP’s primary strategies is to partner with others in the health professions through coalitions. This collective work allows us to advocate for legislation and regulation that is favorable toward the profession and the patients we serve but with a much bigger, more powerful voice. To see coalition letters that AAPP has joined, click here. Partnering with coalitions:
What you need to know about insomnia.
What you need to know about deprescribing.
Characterizing the Relationship Between Individuals with Mental Health Conditions and Community Pharmacists - Results from a 2012 Survey